Ana I. Velázquez Mañana: Broadening access and inclusion in oncology clinical trials
Ana I. Velázquez Mañana shared a post on X:
“Grateful to ASCO for bringing us together to discuss and strategize solutions to broaden access and inclusion in oncology clinical trials.
Plus got to listen to the always enlightening Rob Winn and chat about getting into ‘good trouble’.”
Source: Ana I. Velázquez Mañana/X
Ana Velázquez Mañana is an Assistant Professor of Medicine in the UCSF Division of Hematology/Oncology at Zuckerberg San Francisco General and a thoracic oncologist at the UCSF Helen Diller Family Comprehensive Cancer Center. She serves as Assistant Director of Diversity, Equity, Inclusion, and Accessibility for Trainees of the UCSF Helen Diller Family Comprehensive Cancer Center and co-chairs the UCSF Department of Medicine Fellowship Diversity Committee. Her research, advocacy, and education efforts are focused on promoting and advancing health equity and workforce diversity.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023